Olink technology enables further development of South African research

Olink announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink technology and has become the first service provider using the Olink Target and Olink Flex platforms for targeted protein biomarker discovery on the African continent. D-CYPHR is a new facility co-founded by the Centre for Proteomic and Genomic Research and the Institute of Infectious Disease and Molecular Medicine under the DIPLOMICS network programme, an initiative by the South African Department of Science and Innovation. "Olink is immensely proud to see our technology contributing to the outstanding research efforts in South Africa. We know that our technology will further stimulate the development of groundbreaking science, enhancing the well-being of people around the world," said Jon Heimer, CEO of Olink. "This is an exciting first step in what I’m confident will be a fruitful and collaborative journey."